Formula: | C20H17N3O6S |
Molecular Weight: | 427.44 |
Rotatable Bond Donors: | 4 |
clogP: | 2.33 |
Topological Polar Surface Area: | 108.75 |
Lipinski's RO5: | MW: 427.44 HBA: 9 HBD: 1 RB: 4 LogP: 2.33 |
Rule of Three: | MW: 427.44 HBA: 9 HBD: 1 RB: 4 LogP: 2.33 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS23026 | 0.71 | EOS23026 RDKit 3D 29 32 0 0 0 0 0 0 0 0999 V2000 3.4962 2.9937 -2.2318 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1615 3.5609 -0.9695 O 0 0 0 0 0 0 0 0 0 0 0 0 2.5379 2.6442 -0.1686 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2295 3.0673 1.1233 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5994 2.2012 2.0138 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2667 0.9107 1.6097 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5500 0.4876 0.3102 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2447 -0.8596 -0.1099 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2378 -1.6897 -0.6104 N 0 0 0 0 0 0 0 0 0 0 0 0 1.6264 -2.8292 -0.8233 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3179 -2.7581 -0.4963 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0037 -1.5011 -0.0741 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3391 -1.0869 0.2750 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2333 -1.9148 0.4347 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5017 0.2779 0.3466 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.6644 0.9934 0.6673 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8514 0.3490 1.0177 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9883 1.0855 1.3394 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9443 2.4754 1.3136 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7637 3.1259 0.9647 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6183 2.3949 0.6400 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4330 2.9855 0.2837 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5136 4.4059 0.3257 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4811 -3.9501 -0.7037 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4364 -5.0810 -1.1943 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0834 -4.3938 -1.4205 S 0 0 0 0 0 0 0 0 0 0 0 0 2.3535 -4.2595 -2.8340 O 0 0 0 0 0 0 0 0 0 0 0 0 2.9852 -4.9864 -0.4594 O 0 0 0 0 0 0 0 0 0 0 0 0 2.2021 1.3513 -0.5696 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 1 0 12 13 1 0 13 14 2 0 13 15 1 0 15 16 1 0 16 17 2 0 17 18 1 0 18 19 2 0 19 20 1 0 20 21 2 0 21 22 1 0 22 23 1 0 11 24 1 0 24 25 1 0 25 26 1 0 26 27 2 0 26 28 2 0 7 29 2 0 29 3 1 0 12 8 2 0 21 16 1 0 26 10 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |